KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,480,264 | -28.8% | 77,800 | -10.3% | 0.02% | -36.7% |
| Q2 2023 | $3,484,690 | +44.3% | 86,727 | +53.4% | 0.03% | +30.4% |
| Q1 2023 | $2,414,471 | +24.8% | 56,545 | +40.3% | 0.02% | +43.8% |
| Q4 2022 | $1,935,206 | +96.7% | 40,300 | +122.7% | 0.02% | +77.8% |
| Q1 2022 | $984,000 | +4.8% | 18,097 | +12.8% | 0.01% | 0.0% |
| Q4 2021 | $939,000 | -10.5% | 16,044 | -5.9% | 0.01% | -30.8% |
| Q1 2021 | $1,049,000 | – | 17,046 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,382,641 | $85,102,000 | 10.19% |
| Consonance Capital Management LP | 890,209 | $54,792,000 | 5.84% |
| CHI Advisors LLC | 400,468 | $24,649,000 | 4.94% |
| Fairmount Funds Management LLC | 109,333 | $6,729,000 | 2.84% |
| VR Adviser, LLC | 372,306 | $22,915,000 | 2.49% |
| Opaleye Management Inc. | 157,500 | $9,694,000 | 1.42% |
| Darwin Global Management, Ltd. | 86,887 | $5,348,000 | 1.05% |
| Orbimed Advisors | 1,679,417 | $103,368,000 | 0.97% |
| Nantahala Capital Management | 460,372 | $28,336,000 | 0.83% |
| Eventide Asset Management | 427,414 | $26,307,000 | 0.39% |